Lowry, Salford The tale of a Burnley businessman who gives his town a financial leg-up overeggs the north-south cultural divide, but Pippa Cleary’s bright musical numbers propel the positivity Was ever a musical so eager to be liked, so anxious not to exclude? It is not just the patronising pre-show introduction, which assumes we have never been in a theatre and insists we all hate bankers. It is ...
Lowry, Salford The tale of a Burnley businessman who gives his town a financial leg-up overeggs the north-south cultural divide, but Pippa Cleary’s bright musical numbers propel the positivity Was ever a musical so eager to be liked, so anxious not to exclude? It is not just the patronising pre-show introduction, which assumes we have never been in a theatre and insists we all hate bankers. It is also the pathological number of pop-culture references in Rob Madge’s book. “We’re on your side,” it seems to say, “because we too have heard of Coronation Street, EastEnders, Cher, The Legend of Zelda , Jeremy Beadle, Mamma Mia!, Dirty Dancing, Wonderwall …” The list goes on. The level of insecurity is strange because Bank of Dave: The Musical is a tremendously likable show. The source material is the feelgood true-life story of Dave Fishwick (Sam Lupton), the Burnley businessman whose egalitarian conscience led him to step in where others had failed. Seeing his fellow townsfolk being held back for want of money, he determined to set up a non-profit bank that would treat them with trust and respect. Continue reading...
imaginima/iStock via Getty Images Memory product maker Sandisk ( SNDK ), which was spun off from Western Digital in early 2025, has seen a stunning business turnaround in the last year, transforming from a legacy storage brand into a high-growth AI infrastructure play. An investment in Sandisk, started a year ago, generated a phenomenal stock return of more than 4,000%, and the company's recent ea...
imaginima/iStock via Getty Images Memory product maker Sandisk ( SNDK ), which was spun off from Western Digital in early 2025, has seen a stunning business turnaround in the last year, transforming from a legacy storage brand into a high-growth AI infrastructure play. An investment in Sandisk, started a year ago, generated a phenomenal stock return of more than 4,000%, and the company's recent earnings report for the third fiscal quarter crushed analysts' estimates . While fundamentals in the memory market are strong, Sandisk is now very highly priced, trading at 11.9X this year's revenues. I would caution against buying into the memory maker at this point, as this FOMO-driven rally could yield a sharp pullback for shares of Sandisk in the near future. Data by YCharts Sandisk is Enjoying Massive Margin Expansion on SSD Demand Sandisk has transformed itself into a memory play for investors that benefits from red-hot demand for AI-optimized processors run in Data Centers. Sandisk has pivoted its product mix toward high-value enterprise SSDs in the high-margin Data Center end market, for which the enterprise offers high-density memory products required for the handling of massive AI datasets. As the potency of generative AI models grows, Data Centers need to move massive amounts of data from storage to memory, which requires Sandisk's enterprise SSDs. Since AI-related CapEx is booming right now, Sandisk has successfully positioned itself as a high-leverage beneficiary of the current infrastructure buildout. According to the IDC, server-related AI spending will ramp up massively in the years ahead, providing a longer-term tailwind for Sandisk. IDC In the third fiscal quarter, Sandisk reported revenues totaling $5.95B, showing 251% year-over-year growth and a head-spinning 97% acceleration compared to the previous quarter. Due to extreme demand for NAND products and rising average selling prices for memory products like SSDs, Sandisk reported triple-digit growth for all...
Spanish passengers taken off MV Hondius by medical teams in hazmat suits after being screened for the infection Cruise ship hantavirus outbreak – latest updates An evacuation has begun of passengers onboard a cruise ship at the centre of a deadly outbreak of hantavirus. Spanish passengers wearing blue plastic ponchos and hair coverings were taken off the vessel by medical teams in hazmat suits on ...
Spanish passengers taken off MV Hondius by medical teams in hazmat suits after being screened for the infection Cruise ship hantavirus outbreak – latest updates An evacuation has begun of passengers onboard a cruise ship at the centre of a deadly outbreak of hantavirus. Spanish passengers wearing blue plastic ponchos and hair coverings were taken off the vessel by medical teams in hazmat suits on Sunday morning after being screened for the infection. Continue reading...
Replacing a leader is difficult, as Jeremy Corbyn proved – but MPs can apply pressure, publicly or privately Many Labour MPs believe Keir Starmer will not survive as Labour leader for long enough to fight the next election. What they cannot agree on, however – even after a disastrous set of results in this week’s elections – is how his departure might come about. The Labour rulebook makes it notor...
Replacing a leader is difficult, as Jeremy Corbyn proved – but MPs can apply pressure, publicly or privately Many Labour MPs believe Keir Starmer will not survive as Labour leader for long enough to fight the next election. What they cannot agree on, however – even after a disastrous set of results in this week’s elections – is how his departure might come about. The Labour rulebook makes it notoriously difficult to unseat a party leader: none has been formally ejected in the postwar period, though some, including Tony Blair, have resigned under pressure from their own MPs. Continue reading...
Meta's $10 billion Hyperion project will gobble up an estimated $3.3 billion in tax breaks. It’ll also have plenty of knock-on effects in the surrounding community.
Meta's $10 billion Hyperion project will gobble up an estimated $3.3 billion in tax breaks. It’ll also have plenty of knock-on effects in the surrounding community.
Known for its semiconductor interconnect IP, this tech firm reported a sale by a board member amid ongoing reductions in executive holdings. Antonio J Viana, Director of Arteris (NASDAQ:AIP) , disclosed the sale of 20,000 shares for a transaction value of approximately $601,000 on May 5, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($30.07); post-tr...
Known for its semiconductor interconnect IP, this tech firm reported a sale by a board member amid ongoing reductions in executive holdings. Antonio J Viana, Director of Arteris (NASDAQ:AIP) , disclosed the sale of 20,000 shares for a transaction value of approximately $601,000 on May 5, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($30.07); post-transaction value based on May 5, 2026 market close ($30.13). Continue reading
Earning dividend income is a major part of my investment strategy. My goal is to eventually generate enough passive income to offset my basic living expenses. I like to invest in high-yielding dividend stocks because they should help me reach my goal sooner. Here are my top three to buy this May. Image source: Getty Images. Continue reading
Earning dividend income is a major part of my investment strategy. My goal is to eventually generate enough passive income to offset my basic living expenses. I like to invest in high-yielding dividend stocks because they should help me reach my goal sooner. Here are my top three to buy this May. Image source: Getty Images. Continue reading
Getty Images Krystal Biotech ( KRYS ) is well known for its HSV-1 (Herpes Simplex Virus Type 1) viral vector platform, which is how they tackle Dystrophic Epidermolysis Bullosa (DEB) with their leading asset VYJUVEK. Most traditional gene therapies use AAV (adeno-associated virus) vectors, but the issue with these is that they can be used just once. After being injected, the body builds immunity, ...
Getty Images Krystal Biotech ( KRYS ) is well known for its HSV-1 (Herpes Simplex Virus Type 1) viral vector platform, which is how they tackle Dystrophic Epidermolysis Bullosa (DEB) with their leading asset VYJUVEK. Most traditional gene therapies use AAV (adeno-associated virus) vectors, but the issue with these is that they can be used just once. After being injected, the body builds immunity, and before the immune-stimulating genes can reach the system, they are destroyed. HSV-1 naturally evades the human immune system, and so Krystal's gene therapies can be applied repeatedly. Thanks to VYJUVEK, and mainly the delivery system, Krystal started generating revenue in 2023 ($51 million), and since then this number has climbed to $389 million in 2025 (an increase of 7.6x). VYJUVEK, though, is not the company's flagship asset; that would be their Oncology drug (KB707), based on the same HSV-1 delivery system, still in testing. If KB707 is approved and enters the market, it will likely dwarf revenue from VYJUVEK. Moreover, KB707 is not the only drug in the pipeline, and so, in spite of potential risks and high valuation, I rate Krystal Biotech as a Buy. Revenue Growth ( Financial Modeling Prep) The Cash Engine VYJUVEK treats Dystrophic Epidermolysis Bullosa (DEB), a genetic disease that prevents patients from producing Collagen VII, which is the glue that holds the top layer of skin (epidermis) to the bottom layer (dermis). Without this protein, the skin falls apart. The delivery method is a simple topical gel, which is applied to the patient's wounds. This gel consists of the HSV-1 virus, which has been taken apart, and the harmful viral replication genes were replaced with working copies of the COL7A1 gene. This is the gene patients with DEB are missing and the reason why their skin cells cannot manufacture healthy COL7 proteins. Once it is delivered to the nucleus via the edited HSV-1 virus, the cells pick up the code and start producing good COL7 proteins. These p...
TENERIFE, SPAIN - MAY 10: The MV Hondius arrives in the Granadilla Port on May 10, 2026 in Tenerife, part of the Canary Islands, Spain. (Photo by Chris McGrath/Getty Images) Chris Mcgrath | Getty Images News | Getty Images Spain said it had begun bringing Spanish passengers ashore from the cruise ship that was hit by a hantavirus outbreak anchored near Tenerife on Sunday, with groups of nationals ...
TENERIFE, SPAIN - MAY 10: The MV Hondius arrives in the Granadilla Port on May 10, 2026 in Tenerife, part of the Canary Islands, Spain. (Photo by Chris McGrath/Getty Images) Chris Mcgrath | Getty Images News | Getty Images Spain said it had begun bringing Spanish passengers ashore from the cruise ship that was hit by a hantavirus outbreak anchored near Tenerife on Sunday, with groups of nationals from other countries to follow. Spanish nationals were the first to disembark on small boats in groups of five and be taken to shore, where they were transferred onto buses and taken to the local airport. The passengers, who are not showing any symptoms of the virus, will board a flight back to Madrid on a Spanish military plane and taken to hospital to be quarantined, government officials said, emphasising that they will have no contact with members of the public. The luxury cruise ship left for Spain on Wednesday from the coast of Cape Verde, after the World Health Organization and the European Union asked the country to manage the evacuation of passengers following the detection of a hantavirus outbreak. No rodents detected on the ship Countries including Belgium, France, Germany, Ireland, the U.S., the UK, and the Netherlands confirmed on Saturday that they had sent planes to evacuate their citizens, though local government officials in the Canaries said not all planes had arrived by Sunday morning. The World Health Organization (WHO) said in an update on Friday that eight people no longer on the ship had fallen ill, including three who died — a Dutch couple and a German national; of the eight, six are confirmed to have contracted the virus, with another two suspected cases. All passengers on the MV Hondius are considered high-risk contacts as a precautionary measure, Europe's public health agency said late on Saturday as part of its rapid scientific advice, adding that the risk to the general population remains low. Evacuation by boat of Spanish nationals from the crui...